Y-mAbs Therapeutics, Inc.
YMABDelisted Sep 16, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001722964
Y-mAbs Therapeutics, Inc. was delisted on Sep 16, 2025; its insiders filed their last Form 4 on Sep 19, 2025; 97 institutions reported holding it in 13F filings for Q2 2025, worth $125.9M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Y-mAbs Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 95 | 99 | +4 |
| Shares | 19.5M | 19.7M | +157.5K (+0.8%) |
| Value | $132.4M | $107.3M | −$25.2M (−19.0%) |
New holders (9)
Institutions that held Y-mAbs Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Caligan Partners LP | 23,321 | $127.1K | 0.07% |
| SG Americas Securities, LLC | 18,349 | $100.0K | 0.00% |
| Boothbay Fund Management, LLC | 15,546 | $84.7K | 0.00% |
| Lazard Asset Management LLC | 12,384 | $67.0K | 0.00% |
| Strengthening Families & Communities, LLC | 1,650 | $9.00K | 0.00% |
| Federated Hermes, Inc. | 925 | $5.04K | 0.00% |
| Cutler Group LP | 200 | $1.00K | 0.00% |
| State of Wyoming | 15 | $82 | 0.00% |
| CWM, LLC | 65 | $0 | 0.00% |
Sold out (5)
Institutions that held Y-mAbs Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Jane Street Group, LLC | 40,195 | $272.9K |
| Fox Run Management, L.L.C. | 26,151 | $177.6K |
| Engineers Gate Manager LP | 14,100 | $95.7K |
| Graham Capital Management, L.P. | 10,075 | $68.4K |
| Quantbot Technologies LP | 900 | $6.11K |